Evaluation of viral suppression and medication-related burden among HIV-infected adults in a secondary care facility

IF 1.8 Q3 PHARMACOLOGY & PHARMACY
Erick Wesley Hedima , John David Ohieku , Emmanuel Agada David , Nasiru Yakubu Ikunaiye , Abdulrahman Nasir , Mustapha Ahmed Alfa , Safinat Abubakar , Ismaila Khalifas Bwiyam , Tang’an Zughumnaan Bitrus
{"title":"Evaluation of viral suppression and medication-related burden among HIV-infected adults in a secondary care facility","authors":"Erick Wesley Hedima ,&nbsp;John David Ohieku ,&nbsp;Emmanuel Agada David ,&nbsp;Nasiru Yakubu Ikunaiye ,&nbsp;Abdulrahman Nasir ,&nbsp;Mustapha Ahmed Alfa ,&nbsp;Safinat Abubakar ,&nbsp;Ismaila Khalifas Bwiyam ,&nbsp;Tang’an Zughumnaan Bitrus","doi":"10.1016/j.rcsop.2024.100473","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>People living with HIV/AIDS (PLHIV) are prone to other health issues that may result from the disease or antiretroviral medicines. These persons experience other psychosocial aspects of the illness, which may negatively affect their quality of life and overall treatment outcomes. This study assessed the medication-related burden and virological response of adult PLHIV.</p></div><div><h3>Method</h3><p>This cross-sectional study involved 417 HIV-positive adults who had been on combined antiretroviral therapy for at least a year at the State Specialist Hospital Gombe. Nigeria. Patient medication experience was measured using the Living with Medication Questionnaire version-3 (LMQ-3). Virological suppression was assessed at viral loads &lt;1000 copies/ml and 20 copies/ml for undetectable HIV RNA levels. The LMQ-3 scores were compared with the participants' characteristics using independent <em>t</em>-tests or one-way analysis of variance (ANOVA). Regression analyses was employed to identify the predictors of viral suppression and medication-related burden. <em>P</em> value &lt;0.05 at 95% confidence interval was considered statistically significant.</p></div><div><h3>Results</h3><p>Of the 417 PLHIV included in this study, 271 (65%) were classified as WHO Stage 1 ART initiation, 93.8% achieved viral suppression with 291 (69.5%) whom were females. The majority of patients 382 (91.6%) were on a dolutegravir-based regimen, had no tuberculosis diagnosis at antiretroviral therapy (ART) initiation (82.5%) and were 6–10 years on ART (46.3%). Only 67.6% of the population had a moderate medication-related burden. Female sex (<em>p</em> &lt; 0.0005), unsuppressed viral load (<em>p</em> = 0.01), second-line ART (<em>p</em> = 0.03), tuberculosis at ART initiation (<em>p</em> = 0.02), and employment (<em>p</em> = 0.003) were significantly associated with medication-related burden. The predictor of viral suppression was high degree of medication-related burden (AOR, 0.12; 95% CI, 0.02–0.59) while unsuppressed viral load (<em>p</em> = 0.01) and female gender (<em>p</em> = 0.002) were independent predictors of medication related burden.</p></div><div><h3>Conclusion</h3><p>The findings from this study revealed that majority of the patients achieved viral suppression with moderate degree of medication-related burden. Targeted interventions should be directed toward younger patients, females and patients with unsuppressed viral loads.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667276624000702/pdfft?md5=4a3dd4b882199b604ca1eb9339610145&pid=1-s2.0-S2667276624000702-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667276624000702","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

People living with HIV/AIDS (PLHIV) are prone to other health issues that may result from the disease or antiretroviral medicines. These persons experience other psychosocial aspects of the illness, which may negatively affect their quality of life and overall treatment outcomes. This study assessed the medication-related burden and virological response of adult PLHIV.

Method

This cross-sectional study involved 417 HIV-positive adults who had been on combined antiretroviral therapy for at least a year at the State Specialist Hospital Gombe. Nigeria. Patient medication experience was measured using the Living with Medication Questionnaire version-3 (LMQ-3). Virological suppression was assessed at viral loads <1000 copies/ml and 20 copies/ml for undetectable HIV RNA levels. The LMQ-3 scores were compared with the participants' characteristics using independent t-tests or one-way analysis of variance (ANOVA). Regression analyses was employed to identify the predictors of viral suppression and medication-related burden. P value <0.05 at 95% confidence interval was considered statistically significant.

Results

Of the 417 PLHIV included in this study, 271 (65%) were classified as WHO Stage 1 ART initiation, 93.8% achieved viral suppression with 291 (69.5%) whom were females. The majority of patients 382 (91.6%) were on a dolutegravir-based regimen, had no tuberculosis diagnosis at antiretroviral therapy (ART) initiation (82.5%) and were 6–10 years on ART (46.3%). Only 67.6% of the population had a moderate medication-related burden. Female sex (p < 0.0005), unsuppressed viral load (p = 0.01), second-line ART (p = 0.03), tuberculosis at ART initiation (p = 0.02), and employment (p = 0.003) were significantly associated with medication-related burden. The predictor of viral suppression was high degree of medication-related burden (AOR, 0.12; 95% CI, 0.02–0.59) while unsuppressed viral load (p = 0.01) and female gender (p = 0.002) were independent predictors of medication related burden.

Conclusion

The findings from this study revealed that majority of the patients achieved viral suppression with moderate degree of medication-related burden. Targeted interventions should be directed toward younger patients, females and patients with unsuppressed viral loads.

评估二级医疗机构中感染艾滋病毒的成年人的病毒抑制情况和药物相关负担
背景艾滋病毒/艾滋病感染者(PLHIV)很容易因疾病或抗逆转录病毒药物而出现其他健康问题。这些人还会经历疾病带来的其他社会心理问题,这可能会对他们的生活质量和整体治疗效果产生负面影响。这项横断面研究涉及 417 名艾滋病毒呈阳性的成年人,他们在尼日利亚贡贝州专科医院接受了至少一年的联合抗逆转录病毒治疗。尼日利亚。患者用药体验采用生活用药问卷 3 版 (LMQ-3) 进行测量。病毒载量为 1000 拷贝/毫升时评估病毒抑制情况,检测不到 HIV RNA 水平为 20 拷贝/毫升时评估病毒抑制情况。采用独立 t 检验或单向方差分析(ANOVA)将 LMQ-3 分数与参与者的特征进行比较。回归分析用于确定病毒抑制和药物相关负担的预测因素。结果 在纳入本研究的 417 名艾滋病毒感染者中,271 人(65%)被归类为世界卫生组织抗逆转录病毒疗法第一阶段,93.8% 实现了病毒抑制,其中 291 人(69.5%)为女性。大多数患者 382 人(91.6%)采用多罗替韦治疗方案,82.5% 的患者在开始接受抗逆转录病毒疗法(ART)时未确诊结核病,46.3% 的患者接受抗逆转录病毒疗法 6-10 年。只有 67.6% 的人有中度药物相关负担。女性性别(p < 0.0005)、未抑制的病毒载量(p = 0.01)、二线抗逆转录病毒疗法(p = 0.03)、开始接受抗逆转录病毒疗法时的结核病(p = 0.02)和就业(p = 0.003)与药物相关负担显著相关。病毒抑制的预测因素是药物相关负担程度高(AOR,0.12;95% CI,0.02-0.59),而未抑制的病毒载量(p = 0.01)和女性性别(p = 0.002)是药物相关负担的独立预测因素。应针对年轻患者、女性和病毒载量未得到抑制的患者采取有针对性的干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信